Parasiticides

FDA Expands Elanco’s Credelio™ and Credelio Quattro™ Labels to Include Lyme Disease Prevention and Protection Against Longhorned Tick

The FDA has approved expanded labels for Elanco’s Credelio™ and Credelio Quattro™, adding prevention of Lyme disease and protection against the rapidly spreading longhorned tick—now found in 22 U.S. states.

Cochliomyia hominivorax, the New World screw-worm fly, or screw-worm for short

Elanco’s Credelio™ Receives First FDA Emergency Use Authorization for New World Screwworm in Dogs

The FDA has granted an Emergency Use Authorization for Elanco’s Credelio™ (lotilaner) to treat New World screwworm infestations in dogs—marking the first authorization of its kind as the parasite nears the U.S. border.

Topics

FDA Expands Elanco’s Credelio™ and Credelio Quattro™ Labels to Include Lyme Disease Prevention and Protection Against Longhorned Tick

Elanco’s Credelio™ Receives First FDA Emergency Use Authorization for New World Screwworm in Dogs

Zoetis to Acquire Neogen’s Animal Genomics Business for $160 Million, Expanding Precision Animal Health Portfolio

Zoetis to Participate in Bank of America 2026 Animal Health Summit

Tartar Shield Launches ‘Second Smile’ Initiative Integrating Preventive Dental Care Into Shelter Adoptions

Most U.S. Pet Owners Report High Satisfaction with Their Veterinary Practice, AVMA Data Show

FDA Grants Emergency Use Authorization for NexGard Products to Treat New World Screwworm in Dogs and Cats

FDA Approves NUMELVI™, First Second-Generation JAK Inhibitor for Canine Allergic Dermatitis